ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,730,000 | -3.8% | 119,708 | 0.0% | 0.81% | +17.6% |
| Q2 2019 | $4,918,000 | -46.7% | 119,708 | -39.6% | 0.69% | -49.6% |
| Q1 2019 | $9,233,000 | -49.6% | 198,261 | -52.8% | 1.37% | -47.0% |
| Q4 2018 | $18,304,000 | -50.8% | 420,293 | -35.3% | 2.58% | -12.7% |
| Q3 2018 | $37,200,000 | -30.5% | 650,000 | -41.1% | 2.95% | -45.2% |
| Q2 2018 | $53,563,000 | -11.8% | 1,103,937 | -29.0% | 5.39% | -29.3% |
| Q1 2018 | $60,759,000 | -7.9% | 1,553,937 | 0.0% | 7.62% | -17.6% |
| Q4 2017 | $65,949,000 | +13.7% | 1,553,937 | 0.0% | 9.24% | +22.5% |
| Q3 2017 | $57,993,000 | +22.8% | 1,553,937 | 0.0% | 7.55% | +33.6% |
| Q2 2017 | $47,224,000 | +14.8% | 1,553,937 | 0.0% | 5.65% | +29.0% |
| Q1 2017 | $41,133,000 | +30.0% | 1,553,937 | +25.3% | 4.38% | +45.3% |
| Q4 2016 | $31,649,000 | -3.2% | 1,240,173 | +37.2% | 3.01% | +3.8% |
| Q3 2016 | $32,710,000 | +40.4% | 903,833 | +31.8% | 2.90% | +18.7% |
| Q2 2016 | $23,306,000 | +31.2% | 685,863 | +1.9% | 2.45% | +25.7% |
| Q1 2016 | $17,762,000 | – | 673,063 | – | 1.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |